Clinical Trials in Stoke-on-Trent, Staffordshire
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Bristol-Myers Squibb1,216 enrolled285 locationsNCT05827016
Recruiting
Not Applicable
Shortened High-dose Palliative Radiotherapy for Lung Cancer
Stage IV Lung Cancer
University Hospitals Coventry and Warwickshire NHS Trust37 enrolled4 locationsNCT06483308
Recruiting
Phase 3
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
BioNTech SE621 enrolled138 locationsNCT06712355
Recruiting
Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Pfizer492 enrolled273 locationsNCT06152575
Recruiting
Not Applicable
Performance and Adherence in Children Using Spacers
AsthmaAsthma in Children
University Hospitals of North Midlands NHS Trust100 enrolled1 locationNCT05366309
Recruiting
Not Applicable
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
Kidney Failure, ChronicHyperphosphatemia
The University of Queensland3,600 enrolled115 locationsNCT03573089
Recruiting
Not Applicable
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
Colorectal NeoplasmsNeoplasm MetastasesHepatic Neoplasms
Imperial College London282 enrolled13 locationsNCT02246634
Recruiting
Not Applicable
Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial
Rectal Cancer
Imperial College London441 enrolled10 locationsNCT02704520